Related references
Note: Only part of the references are listed.Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome A MAGNIMS Study
Massimo Filippi et al.
NEUROLOGY (2022)
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age
Dejan Jakimovski et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry
Stefan J. Blaschke et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis
Malthe Faurschou Wandall-Holm et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
From the prodromal stage of multiple sclerosis to disease prevention
Ruth Ann Marrie et al.
NATURE REVIEWS NEUROLOGY (2022)
Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome
Mar Tintore et al.
NEUROLOGY (2021)
Epidemiology and treatment of multiple sclerosis in elderly populations
Caila B. Vaughn et al.
NATURE REVIEWS NEUROLOGY (2019)
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017-continuity and change
Hans-Peter Hartung et al.
CURRENT OPINION IN NEUROLOGY (2019)
Misdiagnosis of multiple sclerosis Impact of the 2017 McDonald criteria on clinical practice
Andrew J. Solomon et al.
NEUROLOGY (2019)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)